Published in J Nucl Med on May 01, 1992
Combined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases. Eur J Nucl Med Mol Imaging (2007) 1.61
Optimal timing of bisphosphonate administration in combination with samarium-153 oxabifore in the treatment of painful metastatic bone disease. World J Nucl Med (2013) 0.92
VALIDATION OF THERAPEUTIC RESPONSE ASSESSMENT BY BONE SCINTIGRAPHY IN PATIENTS WITH BONE-ONLY METASTATIC BREAST CANCERS DURING ZOLEDRONIC ACID TREATMENT: COMPARISON WITH COMPUTED TOMOGRAPHY ASSESSMENT. Fukushima J Med Sci (2015) 0.75
Is ¹⁵³Samarium-ethylene-diamine-tetramethyl-phosphonate (EDTMP) bone uptake influenced by bisphosphonates in patients with castration-resistant prostate cancer? World J Urol (2011) 0.75
Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support. N Engl J Med (1993) 3.18
A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas. Blood (2000) 2.11
(F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma. Clin Cancer Res (2000) 1.89
Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas. Lancet (1995) 1.69
Imaging guidelines for children with Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group Bone Tumor Committee. Pediatr Blood Cancer (2008) 1.66
[(18)F]FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression. Eur J Nucl Med Mol Imaging (2003) 1.62
Samarium-153-EDTMP in bone metastases of hormone refractory prostate carcinoma: a phase I/II trial. J Nucl Med (1993) 1.55
Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody. J Clin Oncol (1989) 1.43
18fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer. J Clin Oncol (2001) 1.35
Effect of vasopressin on electrical potential difference and chloride transport in mouse medullary thick ascending limb of Henle's loop. J Clin Invest (1980) 1.31
Phase I study of (131)I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome. Blood (1999) 1.31
The use of radiolabeled anti-CD33 antibody to augment marrow irradiation prior to marrow transplantation for acute myelogenous leukemia. Transplantation (1992) 1.25
Internal mammary lymph node drainage patterns in patients with breast cancer documented by breast lymphoscintigraphy. Ann Surg Oncol (2001) 1.18
Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue. J Clin Oncol (1998) 1.13
Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma. Cancer (2000) 1.06
Kinetic analysis of 2-[carbon-11]thymidine PET imaging studies: compartmental model and mathematical analysis. J Nucl Med (1998) 1.05
Localization of radiolabeled antimyeloid antibodies in a human acute leukemia xenograft tumor model. Cancer Res (1992) 1.01
Carbon-11-thymidine and FDG to measure therapy response. J Nucl Med (1998) 0.98
Imaging cellular proliferation as a measure of response to therapy. J Clin Pharmacol (2001) 0.97
Imaging of oncologic patients: benefit of combined CT and FDG PET in the diagnosis of malignancy. AJR Am J Roentgenol (1998) 0.97
Radiolabeled anti-CD45 monoclonal antibodies target lymphohematopoietic tissue in the macaque. Blood (1991) 0.92
A method for imaging therapeutic doses of iodine-131 with a clinical gamma camera. J Nucl Med (1992) 0.92
Immunoreactivity assay for labeled anti-melanoma monoclonal antibodies. J Nucl Med (1986) 0.86
Energy-based scatter corrections for scintillation camera images of iodine-131. J Nucl Med (1996) 0.85
Analysis of blood clearance and labeled metabolites for the estrogen receptor tracer [F-18]-16 alpha-fluoroestradiol (FES). Nucl Med Biol (1997) 0.85
A statistical modeling approach to the analysis of spatial patterns of FDG-PET uptake in human sarcoma. IEEE Trans Med Imaging (2011) 0.84
Vascular response to radiation injury in the rat lung. Radiat Res (1992) 0.84
Kinetic analysis of 2-[11C]thymidine PET imaging studies: validation studies. J Nucl Med (1999) 0.84
Preliminary studies of monoclonal antibody lymphoscintigraphy in malignant melanoma. J Nucl Med (1987) 0.83
High-dose radioimmunotherapy of B cell lymphomas. Front Radiat Ther Oncol (1990) 0.80
Identification of interleukin-2-induced complete response in metastatic renal cell carcinoma by FDG PET despite radiographic evidence suggesting persistent tumor. AJR Am J Roentgenol (1997) 0.79
Improving the tumor retention of radioiodinated antibody: aryl carbohydrate adducts. Cancer Res (1990) 0.78
Synthesis and radioiodination of tyramine cellobiose for labeling monoclonal antibodies. Int J Rad Appl Instrum B (1988) 0.78
Localized beta dosimetry of 131I-labeled antibodies in follicular lymphoma. Med Phys (1992) 0.78
Quantification of iodine-131 distribution by gamma camera imaging. Eur J Nucl Med (1991) 0.78
Indium-111 white blood cell scan for infectious complications of polycystic renal disease. J Nucl Med (1985) 0.78
In vitro and in situ magnetic resonance imaging signal features of atherosclerotic plaque-associated lipids. Arterioscler Thromb Vasc Biol (1997) 0.78
High dose radiolabeled antibody therapy of lymphoma. Cancer Res (1990) 0.77
Positron emission tomography: imaging tumor response. Eur J Nucl Med (2000) 0.77
The advantage of protecting the antigen-binding site during antibody labeling. J Nucl Med (1991) 0.75
Myeloablative radiolabeled antibody therapy with autologous bone marrow transplantation for relapsed B cell lymphomas. Cancer Treat Res (1995) 0.75
Biodistribution and dosimetry following infusion of antibodies labeled with large amounts of 131I. Cancer Res (1991) 0.75
Effect of cyclosporine on the uptake of monoclonal antibody to cardiac myosin. J Heart Lung Transplant (1992) 0.75
Is there a better way to deliver total body irradiation? Bone Marrow Transplant (1992) 0.75
Radiolabeled antibody therapy of human B cell lymphomas. Adv Exp Med Biol (1991) 0.75
Will we be able to recognize a better antibody radiopharmaceutical when we make it? Int J Rad Appl Instrum B (1990) 0.75
Targeted therapy for hematologic malignancies: has its promise been realized? Curr Opin Hematol (1995) 0.75
Autoradiolysis of iodinated monoclonal antibody preparations. Int J Rad Appl Instrum B (1986) 0.75
Idiopathic pulmonary fibrosis. Another cause of ventilation/perfusion mismatch. Clin Nucl Med (1986) 0.75
Detection of cardiac allograft rejection and myocyte necrosis by monoclonal antibody to cardiac myosin. Transplantation (1989) 0.75
Technical aspects of sentinel node lymphoscintigraphy for breast cancer. J Nucl Med Technol (1999) 0.75
The use of radiolabeled antibodies in bone marrow transplantation for hematologic malignancies. Cancer Treat Res (1997) 0.75
Radiolabeled antibody therapy of lymphomas. Important Adv Oncol (1995) 0.75